Newly developed theranostics are ushering in a new era of personalized medicine. With approaches ranging from molecular imaging agents to nanoparticles, the goal is detection and treatment based on the…
Read More
Scottsdale Medical Imaging Ltd. (SMIL) will be among the first 16 centers in the nation to offer florbetapir, the only FDA-approved imaging agent for evaluating patients for Alzheimer’s disease. With…